To identify individual gene expression changes associated with tau neuropathology in PSP, we initially focused on meta-analysis results from Cohorts A and B that passed the stringent Bonferroni cutoff meta-analysis p value < 2.80E-06, after adjusting for the 17,857 expression probes which were common to both cohorts. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.